NG-796A

N/A

Report date: 2023/03/09 14:04:14

Base Information

Drug NameNG-796A
Drug Alias NameNG-796A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionInterleukin-12 stimulantsInterleukin-15 stimulantsInterleukin-15 receptor subunit alpha stimulants +[4] 
TargetsInterleukin-12Interleukin-15Interleukin-15 receptor subunit alpha +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesAkamis Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesParker Institute For Cancer ImmunotherapyAkamis Bio Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A